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RESEARCH ARTICLE
RNA-seq analysis and compound screening highlight multiple
signalling pathways regulating secondary cell death after acute
CNS injury in vivo
Chiara Herzog*, David Greenald*, Juan Larraz, Marcus Keatinge and Leah Herrgen‡
ABSTRACT
Understanding the molecular mechanisms that regulate secondary
cell death after acute central nervous system (CNS) injury is critical for
the development of effective neuroprotective drugs. Previous research
has shown that neurotoxic processes including excitotoxicity,
oxidative stress and neuroinflammation can cause secondary cell
death. Nevertheless, clinical trials targeting these processes have
been largely unsuccessful, suggesting that the signalling pathways
underlying secondary cell death remain incompletely understood. Due
to their suitability for live imaging and their amenability to genetic and
pharmacological manipulation, larval zebrafish provide an ideal
platform for studying the regulation of secondary cell death in vivo.
Here, we use RNA-seq gene expression profiling and compound
screening to identify signalling pathways that regulate secondary cell
death after acute neural injury in larval zebrafish. RNA-seq analysis
of genes upregulated in cephalic mpeg1+ macrophage-lineage cells
isolated from mpeg1:GFP transgenic larvae after neural injury
suggested an involvement of cytokine and polyamine signalling in
secondary cell death. Furthermore, screening a library of FDA
approved compounds indicated roles for GABA, serotonin and
dopamine signalling. Overall, our results highlight multiple signalling
pathways that regulate secondary cell death in vivo, and thus provide a
starting point for the development of novel neuroprotective treatments
for patients with CNS injury.
This article has an associated First Person interview with the two first
authors of the paper.
KEY WORDS: CNS injury, Secondary cell death, RNA-seq,
Compound screen, Cellular signalling, Zebrafish
INTRODUCTION
Acute central nervous system (CNS) injury causes the death of neural
cells, which occurs in two phases. Primary cell death is the direct and
immediate consequence of an acute insult such as physical trauma. In
contrast, secondary cell death occurs in the minutes, hours and days
after the initial insult as an indirect result of complex neurotoxic
processes triggered by the primary injury. Secondary cell death plays
an important role in the pathophysiology of acute CNS disorders
such as traumatic brain injury (Loane et al., 2015; Park et al., 2008),
spinal cord injury (Kwon et al., 2004; Oyinbo, 2011), and stroke
(Xing et al., 2012; Yuan, 2009). Importantly, the delayed occurrence
of secondary cell death opens a therapeutic window during which
treatments aimed at reducing or preventing it could be applied.
Accordingly, intense efforts have been made to identify the
molecular and cellular mechanisms that regulate secondary cell
death. This research has shown that cellular processes including
excitotoxicity, oxidative stress and neuroinflammation can
contribute to secondary cell death after acute neural injury.
Excitotoxicity causes neural cell death by excessive stimulation
of glutamate receptors, whereas oxidative stress can kill cells
through the toxic effects of reactive oxygen species. In addition, the
inflammatory response to neural injury plays an important role in
the regulation of secondary cell death. Neuroinflammation was long
thought to be primarily detrimental, but there is an increasing
realisation that it can also have neuroprotective effects (Loane and
Kumar, 2016; Xiong et al., 2016; Zhou et al., 2014). Both brain-
resident microglia and peripheral macrophages are important
cellular effectors of the inflammatory response to neural injury.
They migrate to the site of injury, where they remove dead cells and
cellular debris through phagocytosis (Hanisch and Kettenmann,
2007; Nimmerjahn et al., 2005). Furthermore, microglia and
macrophages respond to CNS injury by secreting a wide range of
effector molecules including pro- and anti-inflammatory cytokines,
chemokines and neurotrophic factors (Anwar et al., 2016; Hellewell
et al., 2016; Mracsko and Veltkamp, 2014).
Despite great efforts to develop neuroprotective treatments for
patients with acute CNS injury, clinical trials of drugs targeting
excitotoxicity, oxidative stress or neuroinflammation after traumatic
brain injury (Chakraborty et al., 2016; Hawryluk and Bullock, 2015;
Maas et al., 2008), spinal cord injury (Ahuja et al., 2017; Kim et al.,
2017) or stroke (Chamorro et al., 2016; Moretti et al., 2015) have
largely failed. This indicates that the signalling pathways that
regulate secondary cell death remain incompletely understood, and
that more research is needed before effective drugs can be developed.
Due to their suitability for live imaging and their amenability to
genetic and pharmacological manipulation, larval zebrafish provide
an ideal platform for the rapid identification of genes and compounds
that modulate secondary cell death in vivo. In previous work, we
established an experimental setup for quantification of secondary
cell death after acute CNS injury in larval zebrafish, and showed that
neurotoxic processes such as excitotoxicity that underlie secondary
cell death in mammals are conserved in this model system (Herzog
et al., 2019). Here we utilise this platform, in combination with
RNA-seq gene expression profiling and compound screening, to
identify signalling pathways that modulate secondary cell death
in vivo. First, we conduct RNA-seq analysis to identify signallingReceived 17 December 2019; Accepted 2 March 2020
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molecules secreted by microglia and macrophages after CNS injury
in larval zebrafish. Our results reveal 17 such factors, including
cytokines, chemokines, growth factors, and enzymes involved in
polyamine and arachidonic acid metabolism. We then use CRISPR/
Cas9-mediated gene knockout to test the involvement of a subset of
these genes in injury-induced cell death, and find that knockout of
the cytokine tnfsf11 or the polyamine-metabolising enzyme Smox
leads to an increase in secondary cell death. Second, we conduct an
imaging-based screen of 786 FDA-approved compounds to identify
small molecules that modulate secondary cell death in vivo. This
revealed two compounds that consistently and specifically change
injury-induced cell death. Of these, the GABA reuptake inhibitor
tiagabine decreases cell death, whereas the serotonin and dopamine
receptor antagonist ziprasidone increases it. Overall, these results
indicate that a range of cellular signalling pathways are involved in
regulating secondary cell death in vivo.
RESULTS
RNA-seq analysis identifies geneswith altered expression in
microglia and macrophages after acute CNS injury
After CNS injury, microglia and macrophages produce pro-
inflammatory cytokines such as TNF-α, IL-1β and IL-6, which can
contribute to neural cell death (Brown and Vilalta, 2015). However,
evidence from in vitro systems suggests that they can also be
neuroprotective (Bernardino et al., 2005; Carlson et al., 1999; Figiel,
2008; Jung et al., 2011; Kadhim et al., 2008; Lambertsen et al., 2009;
Marchetti et al., 2004; Masuch et al., 2016; Turrin and Rivest, 2006).
Furthermore, microglia and macrophages can secrete anti-
inflammatory cytokines such as IL-4 and IL-10, and neurotrophic
factors such as BDNF and NGF (Anwar et al., 2016; Hellewell et al.,
2016; Mracsko and Veltkamp, 2014), in response to neural injury.
Which of these secreted signalling molecules are neurotoxic or
neuroprotective in vivo remains incompletely understood.
Like their mammalian counterparts, microglia and peripheral
macrophages in larval zebrafish respond to CNS injury by migrating
to the injury site, where they phagocytose neural debris (Herzog
et al., 2019;Morsch et al., 2015; Ohnmacht et al., 2016; Sieger et al.,
2012; Tsarouchas et al., 2018). Notably, the core microglia-specific
gene expression signature is also largely conserved between
zebrafish and mammals (Mazzolini et al., 2019; Oosterhof et al.,
2017). To identify signalling molecules produced by microglia and
macrophages after neural injury in larval zebrafish, we first assessed
changes in the transcriptome of macrophage-lineage cells through
RNA-seq analysis. For this, we induced acute CNS injury inmpeg1:
GFP transgenic larvae at 4 days post fertilisation (dpf), where
microglia and peripheral macrophages are labelled (Ellett et al.,
2011). CNS injury was induced by piercing the optic tectum with a
fine metal pin mounted on a micromanipulator. This injury
paradigm induces primary and secondary cell death in neural cells
of the optic tectum, peaking at 0 and 6 h post injury (hpi),
respectively (Herzog et al., 2019). Both microglia and peripheral
macrophages react to injury by starting to migrate towards the injury
site within minutes of the insult, where they continue to accumulate
in the following hours (Herzog et al., 2019; Sieger et al., 2012). We
decided to isolate cephalic macrophage-lineage cells from sham and
injured larvae at 2 hpi (Fig. 1A). This allowed us to study early
transcriptomic changes in microglia and macrophages, which could
plausibly affect the extent of secondary neural cell death at 6 hpi.
Cephalic mpeg1+ macrophage-lineage cells were isolated from
larval heads by fluorescence-activated cell sorting (FACS) following
an established protocol (Mazzolini et al., 2018). The gating
parameters for FACS were adjusted with the help of wild-type
Fig. 1. RNA-Seq analysis reveals genes coding for secreted signalling molecules that are upregulated in microglia and macrophages after acute
neural injury. (A) Workflow for RNA-Seq gene expression profiling. FDR, false discovery rate; FC, fold change; GO, gene ontology. (B) Heat map visualising
z-scores for the 17 upregulated genes coding for secreted factors identified through RNA-Seq analysis.
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samples so as to attain the highest possible purity of sorted mpeg1+
cells (Fig. S1). We initially generated a total of 12 samples of FACS-
purified macrophage-lineage cells for RNA-seq, with six samples
each for the sham and 2 hpi experimental conditions. The number of
mpeg1+ cells was 26,945±1176 per sample, isolated from 183±5
larvae per sample. RNA extraction from sorted cells yielded 10.6
±0.8 ng of total RNA per sample. Assessment of RNA quality
showed an RNA integrity number (RIN) of 10 for all samples, which
represents the highest possible RIN score. The RNA thus obtained
was then reverse transcribed and amplified using a commercially
available kit, yielding 288±21 ng of cDNA per sample.
Libraries were prepared from cDNA and sequenced using next-
generation sequencing, which generated between 23.7 and 36 million
reads per sample. Reads were trimmed, mapped to the Danio rerio
GRCz10 reference genome, counted, filtered and normalised. A
principal component analysis (PCA) was then carried out on filtered
and normalised expression data to explore patterns with respect to
experimental groups. This revealed high duplication and lowmapping
rates for three samples from the 2 hpi experimental group, which did
not cluster well with the other samples in PCA plots (Fig. S2). Since
inclusion of these samples would have caused signals from the
remaining samples to be overwhelmed, they were excluded from
further analysis. Hence, all subsequent analysis was carried out
using six samples for the sham experimental group, and the three
remaining samples for the 2 hpi experimental group. Filtering and
normalisation were repeated for these samples before proceeding.
Differential analysis was then carried out to compare gene expression
between the sham and 2 hpi experimental groups. This identified 426
differentially expressed genes with a false discovery rate (FDR)<0.01
(Fig. 1A). Of these, 348 were upregulated and 78 were
downregulated. These results show that neural injury leads to
changes in the transcriptome of macrophage-lineage cells as early
as 2 hpi. Importantly, the raw and processed data from our RNA-seq
analysis are available through the Gene Expression Omnibus (GEO)
database (accession number GSE140810).
To analyse these transcriptomic changes in more detail, we
performed geneontology (GO) analysis of our set of 426 differentially
regulated genes using the PANTHER Classification system (Mi
et al., 2019). More specifically, we conducted a PANTHER
overrepresentation test to identify the biological processes that these
differentially regulated genes are preferentially involved in (Fig. 2).
Not unexpectedly, this analysis revealed an overrepresentation
of immune-regulatory genes. In addition, genes involved in DNA
replication were overrepresented, possibly indicating a proliferative
response of macrophage-lineage cells to neural injury. Genes that
regulate cellular signalling, metabolism and transcription were also
overrepresented, suggesting that macrophage-lineage cells undergo
profound changes in their cellular state in response to neural injury.
These findings are consistent with previous research showing changes
in immune regulation, proliferation and cellular metabolism in
macrophage-lineage cells after CNS injury in mammals (Anwar
et al., 2016; Hellewell et al., 2016; Mracsko and Veltkamp, 2014).
Expression of a range of secreted signalling molecules is
upregulated in cephalic macrophage-lineage cells after
neural injury
Next, we sought to identify genes coding for secreted signalling
molecules that were upregulated after neural injury, since such
molecules are well placed to have a direct effect on neuronal
survival. For this, we considered upregulated genes with FDR<0.01
and log2FC>1, of which there were 209 (Fig. 1A). Based on the GO
information available for each of these genes, we identified 17
upregulated genes that encode secreted or membrane-bound
signalling molecules, or enzymes that produce secreted signalling
molecules, within this set (Fig. 1A). The 17 genes thus identified
encode molecules from five different categories, including
cytokines, chemokines, growth factors, enzymes involved in
polyamine biosynthesis, and enzymes involved in arachidonic
acid metabolism (Fig. 1B; Table 1). Overall, these results are in
good agreement with findings from mammalian models of neural
injury. In particular, microglia and macrophages are known to
increase the production of cytokines, chemokines and growth
factors after damage to the mammalian CNS (Anwar et al., 2016;
Hellewell et al., 2016; Mracsko and Veltkamp, 2014). Likewise, the
metabolism of polyamines (Kim et al., 2009; Zahedi et al., 2010)
and of arachidonic acid (Adibhatla et al., 2006; López-Vales et al.,
2011; Rink and Khanna, 2011) increases after neural injury in
mammals, even though this has not been specifically linked to
macrophage-lineage cells.
We hypothesised that molecules secreted by microglia and
macrophages can modulate secondary cell death, and sought to test
this hypothesis for a small subset of the 17 upregulated signalling
molecules. For this analysis, we selected three genes from two gene
categories: the cytokine tnfsf11 and the polyamine-metabolising
Fig. 2. Gene ontology analysis shows overrepresentation of genes involved in immune response, proliferation and cellular signalling and
metabolism. A PANTHER overrepresentation test was carried out to identify GO biological process categories overrepresented among the set of 426 genes
with FDR<0.01.
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enzymes odc1 and smox. These genes were chosen because they
were among the most differentially regulated of the secreted
factors (Fig. 1B, Table 1), and because we wanted to analyse the
roles of different genes both within and between different gene
categories.
To validate our RNA-seq results for tnfsf11, odc1 and smox, we
conducted RT-qPCR analysis for these three genes. We performed
RT-qPCR on remaining cDNA samples from our RNA-seq
experiment, and also on freshly generated cDNA samples from
FACS-purified macrophage-lineage cells from sham and injured
larvae at 2 hpi. These experiments indicated upregulation of all three
genes after neural injury (Fig. 3). Hence, our RT-qPCR results
confirmed the injury-induced increase in expression of tnfsf11, odc1
and smox from our RNA-seq analysis.
CRISPR/Cas9-mediated gene knockout allows for rapid
assessment of the role of candidate genes in secondary
cell death
We next sought to test whether tnfsf11, odc1 and smox can modulate
secondary cell death after neural injury in vivo. For this, we used
CRISPR/Cas9-mediated gene editing,wherewe injected a guideRNA
(gRNA) targeting a gene of interest together with Cas9 enzyme into
one-cell-stage embryos. In zebrafish, this efficiently generates
mutations in the targeted gene in a high proportion of cells (Jao
et al., 2013). This approach allows for analysis of gene function in
gRNA-injected F0 animals, which we refer to as ‘crispants’. For each
of our three genes, we generated at least four gRNAs. Each gRNA’s
target sequence was designed to overlap the restriction site of an
endonuclease in one of the gene’s exons. This allowedus to test gRNA
efficiency by assessing the extent of loss of the targeted endonuclease
restriction site in gRNA-injected larvae (Fig. S3). Using this strategy,
we were able to identify at least one gRNAwith ≥80% efficiency for
each gene (Table S1). For genes with two highly efficient gRNAs,
both gRNAs were co-injected in knockout experiments.
To investigate the role of tnfsf11, odc1 and smox in injury-
induced cell death, we used our previously established experimental
setup for quantification of secondary cell death (Herzog et al.,
2019). For this, we induced acute neural injury in the optic tectum of
H2A:GFP transgenic larvae (Pauls et al., 2001), where all cell nuclei
are labelled (Fig. 4A). This enabled us to assess pyknosis, the
condensation of chromatin in the nucleus of a dying cell, as an
in vivo readout for cell death (Fig. 4B). Secondary cell death was
quantified by manual counting of the number of pyknotic nuclei
within the tectum at 6 hpi, the peak of secondary cell death in this
model system (Herzog et al., 2019).
To investigate whether microinjection of gRNAs itself had an
effect on the extent of secondary cell death, we first quantified cell
death at 6 hpi in uninjected animals, in animals injected with Cas9
enzyme but no gRNA, and in animals injected with Cas9 enzyme
and a scrambled gRNA. The scrambled gRNA is a negative
control gRNA targeting the human β-globin intron mutation that
causes β-thalassemia. Our results showed no difference in the
levels of cell death between uninjected larvae and those injected
with no gRNA or scrambled gRNA (Fig. S4). This confirmed that
gRNA microinjection itself does not alter the level of secondary
cell death.
Knockout of the cytokine gene tnfsf11 increases secondary
cell death
We first investigated the role of tnfsf11 in secondary cell death.
Tnfsf11, also known as RANKL, TRANCE, OPGL or ODF, is a
Table 1. Genes encoding secreted factors upregulated in microglia and
macrophages after acute neural injury
Gene
ID
Gene
symbol Gene name log2(FC) FDR
Gene function: Cytokine activity
098700 il1b interleukin 1, beta 2.10 5.57E-10
102318 il6 interleukin 6 2.48 0.0050
035435 m17 IL-6 subfamily cytokine M17 2.31 6.63E-06
068141 tnfsf11 TNF superfamily member 11 2.43 1.57E-06
102211 csf3a colony stimulating factor 3 a 3.82 2.84E-08
098752 csf3b colony stimulating factor 3 b 3.06 0.0002
Gene function: Chemokine activity
094983 ccl34a.3 chemokine (C-C motif)
ligand 34a, duplicate 3
3.84 0.0002
090873 ccl34a.4 chemokine (C-C motif)
ligand 34a, duplicate 4
2.57 1.82E-06
103466 ccl35.1 chemokine (C-C motif)
ligand 35, duplicate 1
1.73 0.0001
104795 cxcl8a chemokine (C-X-C motif)
ligand 8a
3.10 0.0004
Gene function: Growth factor activity
031246 hbegfb heparin-binding EGF-like
growth factor b
1.57 0.0028
012671 inhbaa inhibin subunit beta Aa 1.02 0.0090
Gene function: Polyamine metabolism
007377 odc1 ornithine decarboxylase 1 1.99 3.71E-12
036967 smox spermine oxidase 1.04 2.59E-06
Gene function: Arachidonic acid metabolism
004078 acsl4a acyl-CoA synthetase long
chain family member 4a
1.16 9.13E-05
010752 acsl4b acyl-CoA synthetase long
chain family member 4b
1.69 3.72E-08
062956 dagla diacylglycerol lipase, alpha 1.22 0.0064
Differentially regulated genes for which FDR<0.01 and log2FC>1, and for
which GO analysis indicated that they encode secreted or membrane-bound
signalling molecules, or enzymes that produce secreted signalling molecules,
were included in the list.
Fig. 3. RT-qPCR confirms changes in gene expression detected
through RNA-seq analysis. The changes in tnfsf11, odc1 and smox
expression in FACS-purified macrophage-lineage cells after neural injury
were assessed by RT-qPCR. Each data point was generated by comparing
gene expression in one cDNA sample from injured larvae at 2 hpi with that in
one sample from sham larvae, with both cDNA samples generated on the
same day. Three data points were derived from samples also used for RNA-
seq analysis, and three from freshly generated samples. Sorted cells from
about 180 larvae were pooled for each cDNA sample. Wilcoxon signed rank
test was used to compare experimental groups. P=0.031 for sham versus
injured for all three genes. *P<0.05.
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member of the tumour necrosis factor (TNF) superfamily of
signalling proteins. It is a type II membrane protein that is best
known as a regulator of osteoclast differentiation and immune
system function (Hanada et al., 2011). Tnfsf11 can modulate cell
death through activation of the anti-apoptotic Akt/PKB signalling
pathway (Wada et al., 2006), making it a plausible candidate
regulator of cell death after CNS injury.
Our RNA-seq and RT-qPCR results indicate that the expression
of tnfsf11 is upregulated in macrophage-lineage cells after acute
neural injury (Figs 1B and 3; Table 1). To investigate whether
tnfsf11 can regulate secondary cell death after acute neural injury,
we counted the number of pyknotic nuclei at 6 hpi in tnfsf11
crispants. If tnfsf11 had a neurotoxic or a neuroprotective effect, we
would expect to see a decrease or an increase in cell death after
tnfsf11 knockout. Interestingly, we found that CRISPR/Cas9-
mediated knockout of tnfsf11 lead to a 68% increase in cell death
in injured larvae at 6 hpi (Fig. 4C). Importantly, we did not detect a
difference in cell death after tnfsf11 knockout in sham larvae
(Fig. 4C), indicating that tnfsf11 specifically modulates secondary
cell death rather than changing the background level of cell death.
Overall, these findings are consistent with a neuroprotective effect
of tnfsf11 in the context of acute neural injury.
Fig. 4. See next page for legend.
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Knockout of the polyamine-metabolising gene smox, but not
odc1, increases secondary cell death
Next, we sought to determine whether the polyamine-metabolising
genes odc1 and smox also regulate secondary cell death. Polyamines
such as putrescine, spermidine and spermine are ubiquitous organic
polycations whose presence effects multiple cellular processes. In
the CNS, polyamines modulate the activity of a variety of ion
channels including NMDA receptors (Rock and Macdonald, 1995).
With NMDA receptors acting as key mediators of excitotoxicity
(Dorsett et al., 2017), it is plausible that polyamines could regulate
excitotoxic cell death after acute neural injury.
The odc1 gene encodes ornithine decarboxylase, the rate-limiting
enzyme in the polyamine biosynthesis pathway that catalyses the
conversion of ornithine to putrescine. Interestingly, the expression
of odc1 is upregulated in macrophage-lineage cells after neural
injury (Figs 1B and 3, Table 1), suggesting an increase in the rate of
polyamine biosynthesis in the damaged CNS. To investigate
whether this effects the extent of secondary cell death, we
quantified cell death at 6 hpi in odc1 crispants. Intriguingly, odc1
knockout did not appear to have an effect on secondary cell death
(Fig. 4D).
To confirm our result from odc1 gene knockout, we also sought to
reduce odc1 function pharmacologically. For this, we used the
ornithine decarboxylase inhibitor DFMO, which has been shown to
inhibit polyamine biosynthesis in larval zebrafish (Mastracci et al.,
2015; Mounce et al., 2016). Consistent with our data from odc1
knockout, DFMO treatment had no impact on secondary cell death
(Fig. 4E). Taken together, these results suggest that the overall rate
of polyamine biosynthesis is not a critical factor in regulating
secondary cell death.
We next sought to analyse the role of smox in secondary cell
death. The smox gene encodes spermine oxidase, which catalyses
the oxidation of spermine to spermidine. The expression of smox is
upregulated in macrophage-lineage cells after neural injury (Figs 1B
and 3, Table 1). Interestingly, we found that CRISPR/Cas9-
mediated knockout of smox lead to a 26% increase in cell death in
injured but not sham larvae at 6 hpi (Fig. 4F). This finding is
consistent with a potential neuroprotective role of smox after acute
neural injury. Given the role of smox in converting spermine to
spermidine, this result also raises the possibility that the relative
amounts of spermine and spermidine in the CNS may be important
determinants of the extent of secondary cell death after acute
CNS damage.
An imaging-based compound screen reveals small molecule
modulators of secondary cell death
To complement our work on signalling molecules secreted by
macrophages and microglia, we sought to identify cellular pathways
that regulate secondary cell death in a more unbiased manner. To
this purpose, we conducted an imaging-based compound screen
using the Enzo Life Sciences SCREEN-WELL® FDA-approved
drug library, v.2.0. Each of the 786 drugs in the library is extensively
annotated with regard to its mechanism of action, allowing us to
infer each hit compound’s target signalling pathway. Prior to the
screen, we tested all compounds in the library for systemic toxicity
at 5, 10 and 20 µM. In the screen, each drug was then used at its
highest non-toxic concentration, which was 20 µM for the majority
of the compounds.
For the compound screen, we adapted and partially automated our
in vivo cell-death assay (Fig. 5A). Neural injury was induced in the
optic tectum of H2A:GFP transgenic larvae at 4 dpf. Larvae were
then transferred into 96-well plates, and compounds from the library
were added to each well. At 6 hpi, larvae were automatically imaged
using a Vertebrate Automated Screening Technology (VAST)
system. The VAST platform combines a large particle sampler and a
VAST BioImager (Pardo-Martin et al., 2010) with a customised
spinning disk confocal microscope, thus enabling automated
mounting and imaging of zebrafish larvae. This setup has
previously been used to identify compounds that regulate
myelination in larval zebrafish (Early et al., 2018), highlighting
its suitability for mechanistic investigations of cellular processes in
the larval zebrafish CNS.
To identify compounds that modulate secondary cell death, we
then analysed the images acquired by the VAST platform. To
expedite the image-analysis process, we used a scoring system
where the extent of cell death in drug-treated larvae was categorised
relative to that in DMSO-treated larvae through visual inspection of
the number of pyknotic nuclei in z-stacks of images, rather than
through time-consuming manual counting of pyknotic nuclei. The
scoring categories were ‘decreased’, ‘unchanged’ or ‘increased’ cell
death (Fig. 5B). Compounds that appeared to cause nervous system
toxicity as shown by excessive cell death in the optic tectum were
excluded from further analysis. To assess the reliability of this
scoring system, we conducted an experiment with a small number of
compounds for which scoring had indicated a change in the extent
of cell death during the initial phase of the screen. In this
experiment, we assessed the extent of cell death through scoring and
also quantified the number of pyknotic nuclei at 6 hpi through
manual counting in the same larvae. The scoring results were
confirmed through counting for two of every four compounds
(Table S2), indicating that the scoring system can detect compounds
that modulate cell death. Importantly, previous small molecule
Fig. 4. Reducing the function of tnfsf11 and smox, but not odc1,
increases cell death after acute neural injury. (A) Confocal images of the
optic tectum of sham and injured H2A:GFP transgenic larvae at 6 hpi. The
dashed line indicates the location of the injury site within the cell body layer.
Scale bar: 50 µm. (B) Close-up of regions indicated in (A). White arrows
indicate pyknotic nuclei. Scale bar: 5 µm. (C) Quantification of pyknotic
nuclei within the tectum of uninjected animals, or of animals injected with
tnfsf11 gRNA. n (sham, uninjected)=14 animals. n (sham, tnfsf11 gRNA)=10
animals. n (6 hpi, uninjected)=18 animals. n (6 hpi, tnfsf11 gRNA)=14
animals. N=3 independent experiments. Two-way ANOVA with Bonferroni
correction was used to compare experimental groups. P>0.999 for sham,
uninjected versus sham, tnfsf11 gRNA. P<0.001 for 6 hpi, uninjected versus
6 hpi, tnfsf11 gRNA. **P<0.01. (D) Quantification of pyknotic nuclei within
the tectum of uninjected larvae, or of larvae injected with odc1 gRNA. n
(sham, uninjected)=20 animals. n (sham, odc1 gRNA)=21 animals. n (6 hpi,
uninjected)=24 animals. n (6 hpi, odc1 gRNA)=17 animals. N=4 independent
experiments. Two-way ANOVA with Bonferroni correction was used to
compare experimental groups. P>0.999 for sham, uninjected versus sham,
odc1 gRNA. P=0.331 for 6 hpi, uninjected versus 6 hpi, odc1 gRNA. ns, not
significant. (E) Quantification of pyknotic nuclei within the tectum of larvae
treated with vehicle or DFMO. n (sham, vehicle)=20 animals. n (sham,
DFMO)=18 animals. n (6 hpi, vehicle)=18 animals. n (6 hpi, DFMO)=18
animals. N=2 independent experiments. Two-way ANOVA with Bonferroni
correction was used to compare experimental groups. P>0.999 for sham,
vehicle versus sham, DFMO. P=0.494 for 6 hpi, vehicle versus 6 hpi, DFMO.
(F) Quantification of pyknotic nuclei within the tectum of uninjected animals,
or of animals injected with smox gRNA. n (sham, uninjected)=14 animals. n
(sham, smox gRNA)=15 animals. n (6 hpi, uninjected)=18 animals. n (6 hpi,
smox gRNA)=22 animals. N=3 independent experiments. Two-way ANOVA
with Bonferroni correction was used to compare experimental groups.
P>0.999 for sham, uninjected versus sham, smox gRNA. P=0.036 for 6 hpi,
uninjected versus 6 hpi, smox gRNA. *P<0.05. Note that the data for sham
and 6 hpi uninjected animals are the same in (C) and (F) since larvae in
these groups were processed in the same experiment. ns, not significant.
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screens for modulators of neural regeneration in larval zebrafish
have successfully used similar scoring strategies (Bremer et al.,
2017; Namdaran et al., 2012).
In the initial screen of all 786 compounds from the library, we
identified 22 putative hit compounds. Of these, six decreased cell
death, whereas 16 increased it (Table 2). We then conducted two
further rounds of screening to reassess these initial results. In the
first re-screen, we re-tested the 22 putative hit compounds using
remaining drugs from the library. This confirmed our results from
the initial screen for ten putative hit compounds, of which two
decreased and eight increased cell death (Table 2). In the second
re-screen, we re-tested the ten putative hit compounds from the first
re-screen using freshly ordered compounds. We also included sham
larvae, which enabled us to exclude compounds that change the
background level of cell death instead of specifically modulating
secondary cell death. The second re-screen yielded two putative hit
compounds that specifically regulate secondary cell death, with one
compound decreasing and one increasing it (Table 2).
The putative hit compounds that decreased and increased cell
death were the antiepileptic drug tiagabine and the antipsychotic
medication ziprasidone, respectively. To further confirm the effect
of these putative hits on secondary cell death, we then quantified the
number of pyknotic nuclei at 6 hpi through manual counting, in two
additional experiments for each compound. Importantly, this
substantiated our results from the compound screen for both
drugs. More specifically, we found a 19% decrease in secondary cell
death for tiagabine (Fig. 6A) and a 17% increase for ziprasidone
(Fig. 6B). The extent of cell death in sham larvaewas not affected by
either compound (Fig. 6A,B).
Hence, our drug screen yielded two hit compounds that
consistently and specifically modulate secondary cell death after
acute neural injury in vivo.
DISCUSSION
In the present study, we used our previously established
experimental setup for quantification of secondary cell death in
larval zebrafish (Herzog et al., 2019) to identify signalling pathways
that modulate injury-induced cell death after acute neural injury
in vivo. To this purpose, we combined this platform with RNA-seq
gene expression profiling and compound screening.
We used RNA-seq analysis to investigate early changes in the
transcriptome of cephalic macrophage-lineage cells in larval
zebrafish after acute CNS injury. Our analysis revealed rapid and
pronounced transcriptomic changes in these cells, with more than
400 differentially expressed genes at 2 hpi. Genes associated with
the immune response, DNA replication, and cellular signalling and
metabolism are overrepresented among the differentially expressed
genes (Fig. 2). These results are in agreement with other
transcriptomic studies from both mammals and zebrafish. RNA-
seq analysis of microglia after spinal cord injury in mice revealed
upregulation of genes associated with the immune response and
Fig. 5. The VAST platform enables a partially
automated in vivo imaging-based compound
screen for modulators of secondary cell death.
(A) Workflow for compound screen. A total of three
rounds of screening was carried out, with putative
hits from each round being reassessed in the next
round. (B) VAST images of the optic tectum of H2A:
GFP transgenic larvae at 6 hpi, illustrating the three
cell-death scoring categories used in the compound
screen. The extent of cell death in drug-treated
larvae was scored relative to that in DMSO-treated
control larvae by visual assessment of the amount
of pyknotic nuclei. The dashed line indicates the
location of the injury site within the cell body layer.
White circles indicate pyknotic nuclei. Scale bar:
50 µm.
Table 2. Summary of results from compound screen for modulators of
secondary cell death
Initial
screen
First re-screen (with
library compounds)
Second re-screen
(with fresh compounds)
Number of
compounds
786 22 10
Total putative hits 22 10 2
Putative hits with
decreased cell
death
6 2 1
Putative hits with
increased cell
death
16 8 1
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cellular proliferation (Noristani et al., 2017). Likewise, infiltrating
macrophages increase the expression of immune-system and
metabolic genes after spinal cord injury in mice (Zhu et al.,
2017). In addition, the expression of genes involved in cell cycle
control and DNA replication was shown to change in microglia after
acute neuronal ablation in the brain of adult zebrafish (Oosterhof
et al., 2017). Conversely, another study in adult zebrafish found that
genes upregulated in retinal microglia after neuronal ablation are
mostly associated with vesicle trafficking (Mitchell et al., 2019).
This discrepancy might be due to the later time point of analysis in
the latter study, capturing microglia in a regenerative state rather
than during the acute phase of the injury. Overall, the transcriptional
response of macrophage-lineage cells to acute neural injury appears
to be conserved across vertebrate species, highlighting the relevance
of our model system for the study of microglia and macrophage
reactions to CNS injury. Importantly, all raw and processed RNA-
seq data from our analysis are available through the GEO database
(accession number GSE140810). This dataset will provide a
powerful new resource for studies aiming to understand early
immune-cell reactions to CNS injury.
Which aspects of the response of microglia and macrophages to
CNS injury have neurotoxic or neuroprotective effects is the subject
of ongoing debate (Hu et al., 2015; Li and Barres, 2018). Here we
decided to focus on the role of secreted signalling molecules, since
these have the potential to directly influence neuronal survival. Our
RNA-seq analysis revealed 17 upregulated genes encoding such
factors, including cytokines, chemokines, growth factors and
enzymes involved in polyamine and arachidonic acid biosynthesis
(Table 1). These results highlight the complexity of the
transcriptional response ofmacrophage-lineage cells to neural injury.
One of the cytokines that we found to be upregulated after neural
injury is the TNF superfamily member tnfsf11 (Fig. 1B, Table 1).
Similarly, DNAmicroarray analysis revealed tnfsf11 upregulation in
rat brain tissue after focal ischemia (Schmidt-Kastner et al., 2002). It
is also upregulated after brain ischemia in mice, where its expression
is restricted to microglia and macrophages (Shimamura et al., 2014).
In addition, another study found an increase in expression after
mechanical brain injury in mice (Kelso et al., 2015). Interestingly,
we found that tnfsf11 knockout is associated with an increase in
secondary cell death (Fig. 4C), suggestive of a potential
neuroprotective role. Likewise, infarct volume after ischemia in
mice is increased after treatment with anti-tnfsf11 antibody but
reduced in the presence of recombinant tnfsf11 (Shimamura et al.,
2014). Furthermore, a peptide designed to specifically enhance
tnfsf11 signalling in microglia and macrophages decreases infarct
volume after ischemia in mice (Kurinami et al., 2016; Shimamura
et al., 2018). Together with our results, these findings indicate that
tnfsf11 is upregulated after CNS injury and provide evidence for a
neuroprotective role of tnfsf11 that is conserved across vertebrates.
We found that expression of odc1 and smox, two genes involved
in polyamine metabolism, is also upregulated in macrophage-
lineage cells after neural injury (Fig. 1B, Table 1). Odc1 is the rate-
limiting enzyme in the polyamine biosynthesis pathway, whose
expression level controls the overall rate of polyamine metabolism.
Consistent with our results, odc1 mRNA expression is upregulated
after cerebral ischemia in gerbils (Kindy et al., 1994), and its
enzymatic activity is increased after spinal cord injury (Mautes
et al., 1999), mechanical brain injury (Henley et al., 1996; Rao et al.,
1998) and cerebral ischemia (Babu et al., 2003) in rats. Intriguingly,
we did not detect an effect of odc1 gene knockout (Fig. 4D) or
inhibition of odc1 enzymatic activity with DFMO (Fig. 4E) on
secondary cell death, arguing against a major role of odc1 in this
process. Findings on the role of odc1 in cell death after CNS injury
in mammals are conflicting. DFMO treatment decreases delayed
neuronal cell death after cerebral ischemia in gerbils (Kindy et al.,
1994). Conversely, different levels of putrescine in the mouse brain
are not associated with differences in neuronal death after ischemia
(Lukkarainen et al., 1995). Furthermore, administration of
exogenous putrescine reduces delayed cell death after ischemia in
gerbils (Gilad and Gilad, 1991), and treatment with DFMO
(Lukkarinen et al., 1999) or odc1 antisense oligonucleotides (Rao
et al., 2001) increases infarct volume after ischemia in rats. Overall,
the role of odc1 in cell death after neural injury will require further
investigation.
The smox gene, whose product converts spermine to spermidine,
is also upregulated in macrophage-lineage cells after neural injury
(Fig. 1B, Table 1). Interestingly, increased expression of rat smox
mRNA occurs in the hours after ischemia (Fan et al., 2019) but not
mechanical brain injury (Zahedi et al., 2010). Furthermore, the
levels of spermine and spermidine in brain tissue are decreased after
Fig. 6. The hit compounds tiagabine and ziprasidone change the level of secondary cell death. (A) Quantification of pyknotic nuclei within the tectum
of larvae treated with vehicle or tiagabine. n (sham, vehicle)=32 animals. n (sham, tiagabine)=33 animals. n (6 hpi, vehicle)=53 animals. n (6 hpi,
tiagabine)=53 animals. N=2 independent experiments. Two-way ANOVA with Bonferroni correction was used to compare experimental groups. P=0.936 for
sham, vehicle versus sham, tiagabine. P<0.001 for 6 hpi, vehicle versus 6 hpi, tiagabine. ns, not significant. **P<0.01. (B) Quantification of pyknotic nuclei
within the tectum of larvae treated with vehicle or ziprasidone. n (sham, vehicle)=31 animals. n (sham, ziprasidone)=27 animals. n (6 hpi, vehicle)=41
animals. n (6 hpi, ziprasidone)=34 animals. N=2 independent experiments. Two-way ANOVA with Bonferroni correction was used to compare experimental
groups. P>0.999 for sham, vehicle versus sham, ziprasidone. P=0.024 for 6 hpi, vehicle versus 6 hpi, ziprasidone. ns, not significant. *P<0.05.
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ischemia (Adibhatla et al., 2002) but unchanged after mechanical
brain injury (Henley et al., 1996; Zahedi et al., 2010) in rats. Our
results further indicated a potential neuroprotective role for smox,
since smox gene knockout leads to increased neuronal cell death
after CNS injury (Fig. 4F). Conversely, inhibition of smox
enzymatic activity reduced injury volume after mechanical brain
injury (Doğan et al., 1999) or ischemia (Adibhatla et al., 2002) in
rats. Likewise, ischemic neuronal cell death in rats was decreased
after smox downregulation through RNA interference (Fan et al.,
2019). Consistent with these findings, treatment with exogenous
spermine reduced delayed cell death after ischemia in gerbils (Gilad
and Gilad, 1991) and decreased injury volume following ischemia
in rats (Coert et al., 2000). However, spermine was found to
exacerbate ischemic neuronal injury in mice (Duan et al., 2011).
Hence, it is likely that additional research will be required to define
the role of smox in neuronal damage after acute CNS injury.
Our CRISPR/Cas9-mediated knockout of tnfsf11 and smox
indicated potential neuroprotective roles for both genes. Of note, our
experimental approach did not allow for gene knockout specifically
in macrophage-lineage cells. Thus, knockout of tnfsf11 and smox in
cells other than microglia and macrophages may have contributed to
the increase in secondary cell death in tnfsf11 and smox crispants.
Nevertheless, our results highlight the suitability of our
experimental strategy for rapid identification of neuroprotective
factors after acute neural injury in vivo.
In addition to our RNA-seq analysis of macrophage-lineage cells,
we also performed an imaging-based compound screen to identify
modulators of secondary cell death in a more unbiased manner.
While our previous work had assessed the effect of a small number
of drugs on secondary cell death (Herzog et al., 2019), a systematic
survey of a larger number of molecules has not been carried out. For
the screen, we used the Enzo Life Sciences SCREEN-WELL®
FDA-approved drug library, v.2.0. Being FDA-approved and in use
in the clinic, all compounds in the library have well-characterised
bioactivity, safety and bioavailability profiles, which might help to
accelerate drug development from hit compounds.
We carried out a total of three rounds of screening, with one initial
screen and two re-screens of putative hit compounds from the
previous rounds (Table 2). This strategy allowed us to repeatedly
assess the effect on cell death seen with a particular compound, and
thereby eliminate any false positives. It is possible that some of the
drugs that did not affect cell death when tested at 20 µM in the initial
screen would have had an effect at a higher concentration, and
therefore constitute false negatives. Furthermore, we did not
investigate whether drugs that showed nervous system toxicity in
the initial screen would have specifically affected secondary cell
death at a lower concentration. Hence, we cannot exclude the
possibility that some of these drugs also represent false negatives.
Overall, our screen of 786 small molecules yielded two compounds
that consistently and specifically modulate secondary cell death,
constituting a 0.3% hit rate. Two previous studies describing small
molecule screens for modulators of neural regeneration in larval
zebrafish reported hit rates of 0.5% (Namdaran et al., 2012) and
4.4% (Bremer et al., 2017). This indicates that while relatively low,
our hit rate is still within the range that could reasonably be expected
in this type of screen.
Of our two hit compounds, one decreases and one increases
injury-induced cell death (Table 2). The hit compound that reduces
secondary cell death was tiagabine (Fig. 6A), which is used in the
treatment of epilepsy. Tiagabine increases the level of GABA in the
CNS by blocking the neuronal GABA transporter 1, and it is hence
classified as a GABA reuptake inhibitor (Meldrum and Chapman,
1999). In contrast to tiagabine, the antipsychotic medication
ziprasidone, an antagonist of serotonin and dopamine receptors
(Seeger et al., 1995), increases secondary cell death (Fig. 6B). The
identity of our hit compounds suggests that cellular signalling
through the neurotransmitters GABA, serotonin and dopamine may
play important roles in regulating injury-induced cell death after
acute CNS damage.
Consistent with our finding of reduced secondary cell death in the
presence of tiagabine (Fig. 6A), tiagabine displays neuroprotective
properties in mammalian models of acute CNS injury, potentially
by reducing glutamate-mediated excitotoxicity (Green et al., 2000).
More specifically, tiagabine reduces glutamate levels after ischemia
in gerbils, and this is associated with decreased neuronal cell death
(Inglefield et al., 1995; Iqbal et al., 2002). This result was confirmed
in rats, where tiagabine treatment reduces cell death (Johansen and
Diemer, 1991) as well as injury volume (Chen Xu et al., 2000; Yang
et al., 2000) after ischemia. Our results further support a
neuroprotective effect for tiagabine after acute neural injury.
Unlike tiagabine, ziprasidone increased secondary cell death
(Fig. 6B). Interestingly, this contradicts studies in rats, which
showed a reduction in infarct volume after ischemia in the presence
of ziprasidone (Kaengkan et al., 2013; Kam et al., 2012). The
reasons for this discrepancy remain unclear, but might include
differences in timing or dosage of drug treatment. Hence, more
research will be needed to understand the effect of ziprasidone on
cell death after acute neural injury.
Overall, the work presented here suggests roles for multiple
signalling pathways in the regulation of secondary cell death in vivo,
including the TNF, polyamine, GABA, serotonin- and dopamine-
signalling systems. This highlights the complexity of the cellular
mechanisms that underlie secondary cell death. Our study did not
address whether these signalling systems interact to regulate cell death
after neural injury in vivo. Hence, the extent to which they are diverse
and independent will be an interesting subject for further investigation.
Importantly, our study provides evidence for a neuroprotective
role of the gene tnfsf11 and the small molecule tiagabine, thereby
confirming and extending findings frommammals. This strengthens
the case for using tnfsf11 and tiagabine as starting points for the
development of novel neuroprotective treatments for patients with
CNS injury.
MATERIALS AND METHODS
Fish husbandry
Zebrafish (Danio rerio) of both sexes were used in this study. All animals
were maintained under standard conditions (Westerfield, 2007), and
experiments were performed in accordance with British Home Office
regulations. Wild-type animals were of the AB or WIK strains. Transgenic
lines were H2A.F/Z:GFP (Pauls et al., 2001), referred to as H2A:GFP, and
mpeg1:GFP (Ellett et al., 2011). If necessary, larvae were treated with
100 µM N-phenylthiourea (PTU) to inhibit melanogenesis. All chemicals
were supplied by Sigma-Aldrich unless otherwise stated.
Induction of acute CNS injury
Neural injury in larval zebrafish was induced as previously described
(Herzog et al., 2019). Briefly, zebrafish larvae at 4 dpf were anaesthetised
using 0.01% Ethyl 3-aminobenzoate methanesulfonate (MS-222), and
mounted in 1% low-melting-point agarose (Life Technologies) with their
dorsal side facing upward. The optic tectum was then injured under visual
guidance of a stereomicroscope using a fine metal pin (Fine Science Tools)
mounted on a micromanipulator (Narishige International Ltd.). For
induction of injury, the tip of the metal pin was inserted into the optic
tectum to a depth of approximately 200 µm, and subsequently retracted.
After injury, larvae were carefully released from the agarose and allowed to
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recover for varying amounts of time depending on experimental
requirements. Sham animals were anaesthetised, embedded in agarose and
subsequently released as described, but not injured.
FACS purification and RNA extraction of cephalic macrophage-
lineage cells
To obtain RNA from macrophage-lineage cells for RNA-seq analysis and
RT-qPCR, GFP+ cells were isolated from mpeg1:GFP larvae using FACS,
and RNAwas extracted from sorted cells as previously described (Mazzolini
et al., 2018). All steps were performed at 4°C to preserve RNA integrity.
About 180 larvae were used to generate each sample. Briefly, sham or
injured larvae at 2 hpi were anaesthetised and larval heads were transected
using surgical microscissors (Fine Science Tools). Heads were then
transferred into a glass homogeniser containing 1 ml homogenisation
medium (15 mMHEPES, 2 mMD-Glucose in HBSS) and a cell suspension
was generated by homogenising the tissue. The cell suspension was run
through a 40 µm cell strainer, after which cells were pelleted by
centrifugation. The cell pellet was then resuspended in 1 ml 22% Percoll
and overlaid with 0.5 ml DPBS to create a density gradient. After
centrifugation, the supernatant consisting of DPBS, myelin-containing
interphase and Percoll was discarded and the cell pellet was washed with
0.5 ml homogenisation medium with 2% NGS. The pellet was then
resuspended in 0.5 ml homogenisation medium with 2% NGS and run
through a 35 µm cell-strainer cap into 5 ml FACS tubes. GFP+ cells were
isolated from the cell suspension using a FACSAria II flow cytometer. The
sorting gate for GFP+ cells from mpeg1:GFP larvae was calibrated using
wild-type larvae undergoing the same protocol in order to attain the highest
possible purity of sorted GFP+ cells (Fig. S1). Cells were sorted directly into
1.5 ml tubes containing 1 ml of RNAProtect Cell Reagent (Qiagen) to
stabilise RNA and stored at 4°C for up to 3 days before RNA extraction.
Sorted cells were then pelleted and RNAwas extracted from the pellet using
an RNeasy Plus Micro kit (Qiagen). RNA quantity and quality were
assessed on a LabChip® GX Touch™ 24 nucleic acid analyser
(PerkinElmer).
RNA-seq library preparation, sequencing and analysis
To generate cDNA samples for RNA-seq gene expression profiling, RNA
was reverse transcribed and amplified using the Ovation® RNA-Seq System
V2 (NuGEN). Amplified cDNA was purified using a MinElute Reaction
Cleanup Kit (Qiagen) and quantified on a NanoDrop One spectrophotometer
(Thermo Fisher Scientific).
Library preparation, sequencing and bioinformatics analysis were carried
out by Edinburgh Genomics. Libraries were prepared for each sample using
a manual TruSeq DNA Nano gel-free library kit (Illumina). The samples
were then sequenced on a NovaSeq 6000 instrument. Sequencing reads were
trimmed in Cutadapt (Martin, 2011) and aligned to theDanio rerioGRCz10
reference genome in STAR (Dobin et al., 2013). Reads were assigned to
features of type ‘exon’ using featureCounts (Liao et al., 2014). The raw-
counts table thus generated was filtered to remove genes consisting
predominantly of near-zero counts and reads were normalised using the
weighted trimmed mean of M-values method (Robinson and Oshlack,
2010). A principal components analysis was then undertaken on filtered and
normalised expression data to explore patterns with respect to experimental
factors. The cumulative proportion of variance associated with each factor
was used to study the level of structure in the data, while associations
between continuous value ranges in principal components and categorical
experimental factors was assessed with an ANOVA test. Differential
analysis was carried out with edgeR (Robinson et al., 2010) to compare gene
expression between sham and 2 hpi experimental groups. Fold changes were
estimated as per the default behaviour of edgeR, to avoid artefacts which
occur with empirical calculation. Statistical assessment of differential
expression was carried out using a quasi-likelihood F-test.
GO overrepresentation analysis
GO overrepresentation analysis was carried out using an online tool (http://
www.pantherdb.org) based on the PANTHER classification system (Mi
et al., 2019). For this, a list of differentially expressed genes with FDR<0.01
was uploaded alongside a list of all genes detected in our RNA-seq
experiment. A statistical overrepresentation test was then conducted using
the ‘GO Biological process complete’ annotation set.
Generation of expression heatmap
To generate an expression heatmap for the differentially regulated genes that
encode secreted factors, z-scores for every sample were calculated from
normalised counts for each gene. Heatmaps were created by plotting
z-scores in Prism (GraphPad).
RT-qPCR
For RT-qPCR, cDNAwas synthesised from RNA using the iScript™ cDNA
synthesis kit (Bio-Rad). RT-qPCR was performed on a LightCycler 96
Real-Time PCR system using SsoAdvanced™ Universal SYBR Green
Supermix (Bio-Rad). Primer efficiencies were determined from cDNA
dilution curves. The sequences, product sizes, optimal concentrations and
efficiencies of primers used for RT-qPCR are listed in Table S3. Analysis of
RT-qPCR data was carried out using the Pfaffl Method, which takes primer
efficiency into account (Pfaffl, 2001).
CRISPR/Cas9-mediated gene editing
gRNAs were designed manually to target endonuclease restriction sites in
exonic sequences of genes to be knocked out. At least four gRNAs were
generated for each gene, and their efficiencies were tested by assessing the
extent of loss of their targeted restriction sites through restriction fragment
length polymorphism analysis. For this, 1 nl injection solution containing
crRNAs and tracrRNA (all at 250 ng/µl) together with Cas9 enzyme (NEB)
was injected into one-cell-stage embryos. PCR was performed on genomic
DNA extracted from individual larvae at 24 hpf. The sequences, target
exons and product sizes of primers used for gRNA efficiency testing are
listed in Table S4. PCR products were digested using the appropriate
restriction enzyme (Table S1), and restriction fragments were separated
through agarose gel electrophoresis. The efficiency of each gRNA was
assessed by visual inspection of the relative brightness of the different
restriction fragments (Fig. S3). For this, gel images were carefully inspected
by at least two independent experienced investigators for each gRNA. This
method for assessing gRNA efficiency has previously been validated
through direct sequencing of gRNA target sites (Herzog et al., 2019;
Tsarouchas et al., 2018). Only gRNAs with ≥80% efficiency were used in
knockout experiments. The target sequences, target exons, restriction enzymes
and efficiencies of these gRNAs are listed in Table S1. The target sequence of
the scrambled gRNA was 5′-CCTCTTACCTCAGTTACAATTTATA-3′,
which comprises the human β-globin intron mutation that causes
β-thalassemia.
Drug treatments
Pharmacological agents were delivered by bath application. The following
drugs were used: 10 mM DFMO (Tocris Bioscience); 20 µM imiquimod;
20 µM lindane; 20 µM tiagabine; 20 µM levothyroxine; and 20 µM
ziprasidone (Fluorochem) in 1% DMSO. For vehicle treatment, 1%
DMSO without drug was added to the embryo medium. Drugs were
added to the embryo medium immediately after neural injury.
Image acquisition and analysis
For confocal imaging of crispants, zebrafish larvae were anaesthetised and
mounted in low-melting-point agarose with their dorsal side facing upward.
The agarose was then covered with embryo medium to prevent desiccation
during imaging. Confocal imaging was conducted on a Zeiss LSM 880 laser
scanning microscope. For z-stacks of the optic tectum, images with 3.6 µm
intervals between optical planes were acquired to a depth of 110 µm, starting
at the dorsal side of the tectum.
Quantification of cell death was carried out as previously described
(Herzog et al., 2019). Briefly, pyknotic nuclei within the tectum of H2A:
GFP animals were manually counted in ImageJ (https://imagej.nih.gov/ij)
across both tectal hemispheres and across all consecutive images of z-stacks
of the optic tectum. Pyknotic nuclei display decreased size and increased
brightness when compared to live nuclei (Herzog et al., 2019), and these
parameters were used as the main criteria for identifying individual nuclei as
pyknotic.
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Small molecule screen
We used the Enzo Life Sciences SCREEN-WELL® FDA-approved drug
library, v.2.0, which contains 786 compounds of known bioactivity, safety
and bioavailability. Library compounds are predominantly supplied at
10 mM in DMSO, with a small number of compounds supplied at different
concentrations or in water.
Before the start of the screen, all compounds were tested for systemic
toxicity at a range of concentrations. For this, wild-type larvae at 4 dpf were
distributed into 96-well plates at a density of three larvae per well, and
incubated with library compounds at 5, 10 or 20 µM in 300 µl embryo
medium with PTU and 1% DMSO for 6 h. Larvae were then assessed for
indicators of systemic toxicity such as lethality or abnormal body shape. In
the screen, each compound was used at the highest concentration that did not
induce systemic toxicity. Compounds that showed systemic toxicity at 5 µM
were used at 1 µM in the screen.
In the initial screen, acute neural injury was induced in H2A:GFP larvae,
and larvae were transferred into 96-well plates at a density of two larvae per
well. For each library compound, six larvae were incubated with the
compound in 300 µl embryo medium with PTU and 1% DMSO for 6 h.
Larvae were then anaesthetised and automatically imaged using the VAST
system (Pardo-Martin et al., 2010). This platform uses a Large Particle
Sampler (Union Biometrica) to transfer larvae from each well of a 96-well
plate to a BioImager (Union Biometrica), where it automatically orients
them within a thin-walled glass capillary to allow imaging from the dorsal
side. The BioImager platform is combined with a Zeiss Axio Examiner D1
microscope, fitted with a high-speed CSU-X1 spinning disk confocal
scanner and a Zeiss AxioCam 506m CCD camera. For z-stacks of the optic
tectum, 20 images with 10 µm intervals between optical planes were
acquired. Larvae were imaged in the same order as compounds were added
to the plate in order to ensure similar treatment times across larvae.
Image files from the VAST system were processed to attach well-position
information (Early et al., 2018). The extent of cell death in drug-treated
larvae relative to that in DMSO-treated larvae was then manually scored in
ImageJ. Scoring was conducted by visual inspection of the amount of
pyknotic nuclei in z-stacks of images, with images from DMSO-treated and
drug-treated larvae being viewed side by side. Scoring categories were
‘decreased’, ‘unchanged’ or ‘increased’ cell death (Fig. 5B). Drug-treated
larvae from each plate were scored relative to DMSO-treated larvae from the
same plate in order to control for variation between experiments. All scoring
was performed by the same investigator.
In the first re-screen, putative hits from the initial screen were re-tested
with remaining compound from the library using the same experimental
parameters as in the initial screen. In the second re-screen, putative hits from
the first re-screen were re-tested with freshly ordered compound. Both sham
and injured larvae were included in the second re-screen, and 12 larvae per
experimental group were tested.
To quantify cell death in larvae treated with DFMO, imiquimod, lindane,
tiagabine, levothyroxine or ziprasidone, z-stacks of the optic tectum were
acquired on the VAST system. Pyknotic nuclei within the optic tectum were
manually counted in ImageJ across both tectal hemispheres and across
13 consecutive optical planes from the z-stack, starting at the dorsal side of
the tectum.
Experimental design and statistical analysis
Animals were randomly allocated to experimental groups before the start of
each experiment. Researchers were blinded to experimental group for data
analysis.
All population data are presented as mean±SEM. Statistical analysis was
performed using Prism. Briefly, data sets were assessed for normality, and
appropriate statistical tests were carried out as stated in the figure legends.
Acknowledgements
The authors thank the BVS zebrafish facility (QMRI, University of Edinburgh) for
maintenance and care of the zebrafish. We are grateful to Shonna Johnston for help
with flow cytometry; to Pamela Brown for help with RNA quantity and quality
measurements; to Linda Ferguson for help with RT-qPCR; to Jason Early and Katy
Cole for help with VAST screening, and to the Becker, Lyons and Sieger labs for
sharing reagents and protocols. We thank Jill Fowler and Dirk Sieger for critical
reading of the manuscript.
Competing interests
M.K.’s salary was paid through a collaborative grant from Biogen; this did not have
any influence on study design or interpretation. The other authors declare no
competing or financial interests.
Author contributions
Conceptualization: C.H., D.G., L.H.; Methodology: C.H., D.G., J.L., M.K., L.H.;
Formal analysis: C.H., D.G., J.L., L.H.; Investigation: C.H., D.G., J.L.;
Writing - original draft: L.H.; Writing - review & editing: C.H., D.G., J.L., L.H.;
Supervision: M.K., L.H.; Project administration: L.H.; Funding acquisition: L.H.
Funding
This work was supported by a University of Edinburgh Chancellor’s Fellowship to
L.H.; a Wellcome Trust/The University of Edinburgh Institutional Strategic Support
Fund to L.H.; a Wellcome Trust Seed Award in Science (207701/Z/17/Z to L.H.); a
Carnegie Trust Research Incentive Grant (70457 to L.H.); a Rosetrees Trust/
Stoneygate Trust Seedcorn Award (M602 to L.H.); and a Royal Society Research
Grant (RG170428 to L.H.). Analyses of RNA-seq datawere carried out by Edinburgh
Genomics at the University of Edinburgh. Edinburgh Genomics is partly supported
through core grants from NERC (R8/H10/56), MRC (MR/K001744/1) and BBSRC
(BB/J004243/1).
Data availability
Raw and processed data from RNA-seq gene expression profiling are available
through the GEO database (https://www.ncbi.nlm.nih.gov/geo/) using accession
number GSE140810.
Supplementary information
Supplementary information available online at
http://bio.biologists.org/lookup/doi/10.1242/bio.050260.supplemental
References
Adibhatla, R. M., Hatcher, J. F., Sailor, K. and Dempsey, R. J. (2002). Polyamines
and central nervous system injury: spermine and spermidine decrease following
transient focal cerebral ischemia in spontaneously hypertensive rats. Brain Res.
938, 81-86. doi:10.1016/S0006-8993(02)02447-2
Adibhatla, R. M., Hatcher, J. F. andDempsey, R. J. (2006). Lipids and lipidomics in
brain injury and diseases. AAPS J. 8, E314-E321. doi:10.1007/BF02854902
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A. and
Fehlings, M. G. (2017). Traumatic spinal cord injury. Nat. Rev. Dis. Primers 3,
17018. doi:10.1038/nrdp.2017.18
Anwar, M. A., Al Shehabi, T. S. and Eid, A. H. (2016). Inflammogenesis of
secondary spinal cord injury. Front. Cell Neurosci. 10, 98. doi:10.3389/fncel.2016.
00098
Babu, G. N., Sailor, K. A., Beck, J., Sun, D. and Dempsey, R. J. (2003). Ornithine
decarboxylase activity in in vivo and in vitro models of cerebral ischemia.
Neurochem. Res. 28, 1851-1857. doi:10.1023/A:1026123809033
Bernardino, L., Xapelli, S., Silva, A. P., Jakobsen, B., Poulsen, F. R., Oliveira,
C. R., Vezzani, A., Malva, J. O. and Zimmer, J. (2005). Modulator effects of
interleukin-1β and tumor necrosis factor-α on AMPA-induced excitotoxicity in
mouse organotypic hippocampal slice cultures. J. Neurosci. 25, 6734-6744.
doi:10.1523/JNEUROSCI.1510-05.2005
Bremer, J., Skinner, J. and Granato, M. (2017). A small molecule screen identifies
in vivo modulators of peripheral nerve regeneration in zebrafish. PLoS ONE 12,
e0178854. doi:10.1371/journal.pone.0178854
Brown, G. C. and Vilalta, A. (2015). How microglia kill neurons. Brain Res. 1628,
288-297. doi:10.1016/j.brainres.2015.08.031
Carlson, N. G., Wieggel, W. A., Chen, J., Bacchi, A., Rogers, S. W. and Gahring,
L. C. (1999). Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha
impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol.
163, 3963-3968.
Chakraborty, S., Skolnick, B. and Narayan, R. K. (2016). Neuroprotection trials in
traumatic brain injury. Curr. Neurol. Neurosci. Rep. 16, 29. doi:10.1007/s11910-
016-0625-x
Chamorro, Á., Dirnagl, U., Urra, X. and Planas, A. M. (2016). Neuroprotection in
acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and
inflammation. Lancet Neurol. 15, 869-881. doi:10.1016/S1474-4422(16)00114-9
Chen Xu, W., Yi, Y., Qiu, L. and Shuaib, A. (2000). Neuroprotective activity of
tiagabine in a focal embolic model of cerebral ischemia. Brain Res. 874, 75-77.
doi:10.1016/S0006-8993(00)02554-3
Coert, B. A., Anderson, R. E. and Meyer, F. B. (2000). Exogenous spermine
reduces ischemic damage in a model of focal cerebral ischemia in the rat.
Neurosci. Lett. 282, 5-8. doi:10.1016/S0304-3940(00)00856-9
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut,
P., Chaisson, M. and Gingeras, T. R. (2013). STAR: ultrafast universal RNA-seq
aligner. Bioinformatics 29, 15-21. doi:10.1093/bioinformatics/bts635
11
RESEARCH ARTICLE Biology Open (2020) 9, bio050260. doi:10.1242/bio.050260
B
io
lo
g
y
O
p
en
 by guest on May 11, 2020http://bio.biologists.org/Downloaded from 
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